tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Recursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
PremiumCompany AnnouncementsRecursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
17d ago
Recursion Pharmaceuticals: Balancing AI Advancements with Financial Prudence Justifies Hold Rating
Premium
Ratings
Recursion Pharmaceuticals: Balancing AI Advancements with Financial Prudence Justifies Hold Rating
17d ago
Recursion Pharmaceuticals: Strong Financial Position and Strategic Focus Justify Buy Rating
Premium
Ratings
Recursion Pharmaceuticals: Strong Financial Position and Strategic Focus Justify Buy Rating
17d ago
Recursion Pharmaceuticals rises 16.8%
PremiumThe FlyRecursion Pharmaceuticals rises 16.8%
1M ago
Unusually active option classes on open July 21st
Premium
The Fly
Unusually active option classes on open July 21st
1M ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
1M ago
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
Strategic Acquisition and Market Positioning Drive Buy Rating for Recursion Pharmaceuticals
Premium
Ratings
Strategic Acquisition and Market Positioning Drive Buy Rating for Recursion Pharmaceuticals
2M ago
Recursion Pharmaceuticals Acquires ENPP1 Inhibitor Program
Premium
Company Announcements
Recursion Pharmaceuticals Acquires ENPP1 Inhibitor Program
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100